2 hours Globus Medical (NYSE:GMED) Price Target Raised to $80.00 at Royal Bank of Canada MarketBeat
Royal Bank of Canada lifted their price target on shares of Globus Medical from $78.00 to $80.00 and gave the stock an “outperform” rating in a research note on Tuesday.
Canada · NYSE · Royal Bank of Canada · Science